Economic TimesLean R·
Gland Pharma eyes $100m revenue with new deal
Gland Pharma has entered into a strategic Manufacturing and Supply Agreement (MSA) with a leading global pharmaceutical company to undertake technology transfer, manufacturing and supply of sterile injectable products for global markets, the company said on Sunday.The agreement covers 55 SKUs to be manufactured across three Gland Pharma sites, with scope for additional products to be added. Once the portfolio is fully commercialised, the agreement is expected to have an annualised revenue poten…
Read at Economic Times →
